Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021
May 06 2021 - 6:00AM
Liquidia Corporation (NASDAQ: LQDA) announced today that it will
report its first quarter 2021 financial results on Thursday, May
13, 2021. The company will host a webcast and conference call at
8:30 a.m. Eastern Daylight Time to discuss financial results and
provide a corporate update.
The live call may be accessed by dialing 1-877-707-8711
(domestic) or 1-857-270-6219 (international) and entering the
conference code: 2007727. A webcast of the call will be available
and archived on Liquidia’s website at
https://liquidia.com/index.php/investors/events-and-presentations.
About Liquidia CorporationLiquidia
Corporation is a biopharmaceutical company focused on the
development and commercialization of products in pulmonary
hypertension and other applications of its PRINT® Technology. The
company operates through its two wholly owned subsidiaries,
Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia
Technologies is developing LIQ861, an inhaled dry powder
formulation of treprostinil for the treatment of PAH. Liquidia PAH
provides the commercialization for rare disease pharmaceutical
products, such as Treprostinil Injection. For more information,
please visit www.liquidia.com.
Contact InformationMedia &
Investors:Jason AdairVice President, Corporate Development
and Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2024 to May 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From May 2023 to May 2024